378 related articles for article (PubMed ID: 31176695)
1. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.
Yao I; Stein ES; Maggio N
Pharmacol Ther; 2019 Oct; 202():32-39. PubMed ID: 31176695
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid treatments in epilepsy and seizure disorders.
Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
[TBL] [Abstract][Full Text] [Related]
6. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
7. Cannabis's chemical synergies.
Worth T
Nature; 2019 Aug; 572(7771):S12-S13. PubMed ID: 31462791
[No Abstract] [Full Text] [Related]
8. Examining the role of cannabinoids on osteoporosis: a review.
Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
[TBL] [Abstract][Full Text] [Related]
9. Constituents of Cannabis Sativa.
Rock EM; Parker LA
Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
[TBL] [Abstract][Full Text] [Related]
10. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in the Treatment of Epilepsy.
Friedman D; Devinsky O
N Engl J Med; 2015 Sep; 373(11):1048-58. PubMed ID: 26352816
[No Abstract] [Full Text] [Related]
12. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
Friedman D; Sirven JI
Epilepsy Behav; 2017 May; 70(Pt B):298-301. PubMed ID: 28089286
[TBL] [Abstract][Full Text] [Related]
13. Neuromolecular Mechanisms of Cannabis Action.
Adel Y; Alexander SPH
Adv Exp Med Biol; 2021; 1264():15-28. PubMed ID: 33332001
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA; Raup-Konsavage WM; Vrana KE
Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid therapy in epilepsy.
Billakota S; Devinsky O; Marsh E
Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
[TBL] [Abstract][Full Text] [Related]
17. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
18.
Canseco-Alba A; Rodríguez-Manzo G
Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids in treatment-resistant epilepsy: A review.
O'Connell BK; Gloss D; Devinsky O
Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
